שווי מצרפי של נכסים: Organon & Co (OGN)

Organon & Co. (OGN) demonstrates a financial base formed by wholesale supplies of contraceptives and biosimilars to global clinics, with the indicator value reaching 13312.10. Stable management has successfully adapted the structure following the business spin-off, focusing on portfolio expansion. The technology stack is augmented by AI platforms and robotic lines, reducing manual labor costs and defect rates.

Total assets determine the aggregate volume of the firm's resources and liabilities, while a reverse calculation via ROA allows for real-time tracking of balance sheet dynamics. By analyzing asset trends through ROA, an investor assesses the stability of the Organon & Co. (OGN) base against a backdrop of high debt leverage and the risks of losing patent protection for key women's health drugs.